Skip to main content

Table 1 Clinicopathological characteristics of trial patients according to PCMT1 expression

From: Genome-wide CRISPR/Cas9 library screen identifies PCMT1 as a critical driver of ovarian cancer metastasis

Characteristic

Patients

PCMT1 expression

NO

High

Low

P-Value

All patients

72

50

22

 

 Age (years)

   

0.7175

   ≤ 50

24

16

8

 

   > 50

48

34

14

 

Primary tumor size (cm)

   

0.7677

  ≤ 5

18

12

6

 

  > 5

54

38

16

 

Metastatic tumor size (cm)

   

0.0466

  ≤ 5

64

42

22

 

  > 5

8

8

0

 

Lymphovascular invasion

   

0.6873

 Positive

12

8

4

 

 Negative

60

35

25

 

FIGO stage

   

0.0386

 I/II

18

9

9

 

 III/IV

54

41

13

 

Histology Diagnosis

   

0.3455

 serous

68

49

19

 

 Others

4

2

2

Â